5.0
Jul 4, 2008
Recommend
CEO approval
Business Outlook
Pros
Benefits & long-term opportunity. One of the biggest and still most stable names in biotechnology. Outstanding benefits, especially bonuses, 401k, and generous tuition reimbursement. Brilliant co-workers and collaborative environment. Solid drug pipeline. Products have significant impact and it is thoroughly satisfying to be contributing to what the company is accomplishing. Extensive track record of dramatically improving thousands of lives in an array of disease categories.
Cons
Current uncertainty in ESA franchise, few promotion opportunities available until stability returns (though every other form of career advancement is available). Significant job nesting.